,88 Exogenous addition of IL-6 stimulated stem cell properties (marker gene expression and spheroid formation) and sorafenib resistance in HCC cells, whereas neutralizing IL-6 in CAF-CM or depleting hepatic STAT3 alleviated these effects.87 The gene discussed is STAT3; the disease is hepatocellular carcinoma.